Arcutis Biotherapeutics, Inc. — All Filings
773 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
10-Q/A
144
144/A
3
3/A
4
4/A
424B4
424B5
5
8-A12B
8-K
8-K/A
ARS
CERT
CORRESP
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
S-1
S-1/A
S-1MEF
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SC TO-C
SC TO-I
SC TO-I/A
SCHEDULE 13D/A
SCHEDULE 13G/A
SEC STAFF LETTER
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| 144 | — | 0001628280-25-053781 | Nov 24, 2025 | — |
| 144 | — | 0001628280-25-053785 | Nov 24, 2025 | — |
| 4 | FORM 4 | 0001801061-25-000012 | Nov 24, 2025 | Nov 21, 2025 |
| 4 | FORM 4 | 0001601360-25-000007 | Nov 21, 2025 | Nov 20, 2025 |
| 4 | FORM 4 | 0001798679-25-000006 | Nov 21, 2025 | Nov 19, 2025 |
| 144 | — | 0001628280-25-053625 | Nov 21, 2025 | — |
| 144 | — | 0001628280-25-053397 | Nov 20, 2025 | — |
| 144 | — | 0001628280-25-053185 | Nov 19, 2025 | — |
| 4 | FORM 4 | 0001416180-25-000009 | Nov 17, 2025 | Nov 13, 2025 |
| 4 | FORM 4 | 0001866171-25-000007 | Nov 17, 2025 | Nov 13, 2025 |
| 144 | — | 0001628280-25-052006 | Nov 13, 2025 | — |
| 4 | FORM 4 | 0001741987-25-000008 | Nov 10, 2025 | Nov 6, 2025 |
| 4 | FORM 4 | 0001994805-25-000008 | Nov 10, 2025 | Nov 6, 2025 |
| 144 | — | 0001628280-25-050344 | Nov 6, 2025 | — |
| 144/A | — | 0001628280-25-050285 | Nov 6, 2025 | — |
| 4 | FORM 4 | 0001801050-25-000007 | Nov 5, 2025 | Nov 3, 2025 |
| 4 | FORM 4 | 0001741987-25-000005 | Nov 5, 2025 | Nov 3, 2025 |
| 4 | FORM 4 | 0002065881-25-000035 | Nov 5, 2025 | Nov 3, 2025 |
| 144 | — | 0001628280-25-049708 | Nov 5, 2025 | — |
| 4 | FORM 4 | 0001798679-25-000004 | Nov 5, 2025 | Nov 3, 2025 |
| 4 | FORM 4 | 0001801061-25-000010 | Nov 5, 2025 | Nov 3, 2025 |
| 144 | — | 0001628280-25-048401 | Nov 3, 2025 | — |
| 144 | — | 0001628280-25-048335 | Nov 3, 2025 | — |
| 144 | — | 0001628280-25-048405 | Nov 3, 2025 | — |
| 144 | — | 0001628280-25-048407 | Nov 3, 2025 | — |
| 144 | — | 0001628280-25-048399 | Nov 3, 2025 | — |
| 4 | FORM 4 | 0001801061-25-000008 | Oct 30, 2025 | Oct 28, 2025 |
| 144 | — | 0001628280-25-046746 | Oct 28, 2025 | — |
| 8-K | 8-K | 0001787306-25-000142 | Oct 28, 2025 | — |
| 10-Q | 10-Q | 0001787306-25-000144 | Oct 28, 2025 | Sep 30, 2025 |
| SCHEDULE 13G/A | — | 0000053417-25-000086 | Oct 6, 2025 | — |
| 4 | FORM 4 | 0001994805-25-000005 | Oct 6, 2025 | Oct 2, 2025 |
| 4 | FORM 4 | 0001801050-25-000005 | Oct 3, 2025 | Oct 1, 2025 |
| 4 | FORM 4 | 0001801061-25-000006 | Oct 3, 2025 | Oct 1, 2025 |
| 144 | — | 0001628280-25-043767 | Oct 2, 2025 | — |
| 144 | — | 0001628280-25-043769 | Oct 2, 2025 | — |
| 144 | — | 0001628280-25-043501 | Oct 1, 2025 | — |
| 144 | — | 0001628280-25-043391 | Oct 1, 2025 | — |
| 4 | FORM 4 | 0001787306-25-000136 | Sep 10, 2025 | Sep 8, 2025 |
| 144 | — | 0002007317-25-001055 | Sep 9, 2025 | — |
| 144 | — | 0002007317-25-001047 | Sep 8, 2025 | — |
| 4 | FORM 4 | 0001787306-25-000134 | Sep 8, 2025 | Sep 4, 2025 |
| 144 | — | 0002007317-25-001027 | Sep 4, 2025 | — |
| 4 | FORM 4 | 0001787306-25-000132 | Sep 4, 2025 | Sep 2, 2025 |
| 144 | — | 0002007317-25-001006 | Sep 2, 2025 | — |
| 144 | — | 0002007317-25-000935 | Aug 21, 2025 | — |
| 4 | FORM 4 | 0001787306-25-000130 | Aug 21, 2025 | Aug 19, 2025 |
| SCHEDULE 13D/A | — | 0001415889-25-022498 | Aug 20, 2025 | — |
| 144 | — | 0002007317-25-000901 | Aug 19, 2025 | — |
| SCHEDULE 13G/A | — | 0001172661-25-003250 | Aug 14, 2025 | — |